Barbara Kahn - 18 May 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Barbara Kahn
Issuer symbol
DXCM
Transactions as of
18 May 2023
Net transactions value
+$2.93
Form type
4
Filing time
22 May 2023, 15:48:08 UTC
Previous filing
23 May 2022
Next filing
21 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $2.93 +2,927 +74% $0.001000* 6,903 18 May 2023 Direct F1
transaction DXCM Common Stock Gift $0 -3,976 -58% $0.000000 2,927 18 May 2023 Direct F2
transaction DXCM Common Stock Gift $0 +3,976 +25% $0.000000 19,648 18 May 2023 by Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Shares were transferred from direct ownership to ownership under the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, upon vesting of previously awarded restricted stock units.
F3 Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee.